EDITORIAL
Published on 08 Dec 2021
Editorial: Neuroprotection and Disease Modification in Parkinson’s Disease
doi 10.3389/fphar.2021.813471
- 1,319 views
- Frontiers in Pharmacology
- Neuropharmacology
- Research Topics
- Neuroprotection and Disease Modification in Parkinson’s Disease, Volume I
Neuroprotection and Disease Modification in Parkinson’s Disease, Volume I
16k
Total Downloads
54k
Total Views and Downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
REVIEW
Published on 23 Nov 2021
Pharmacological Modulation of Nrf2/HO-1 Signaling Pathway as a Therapeutic Target of Parkinson’s Disease
doi 10.3389/fphar.2021.757161
- 8,121 views
- 67 citations
ORIGINAL RESEARCH
Published on 31 May 2021
Edaravone Plays Protective Effects on LPS-Induced Microglia by Switching M1/M2 Phenotypes and Regulating NLRP3 Inflammasome Activation
doi 10.3389/fphar.2021.691773
- 4,666 views
- 26 citations
ORIGINAL RESEARCH
Published on 28 May 2021
Dl-3-n-Butylphthalide Alleviates Behavioral and Cognitive Symptoms Via Modulating Mitochondrial Dynamics in the A53T-α-Synuclein Mouse Model of Parkinson’s Disease
doi 10.3389/fnins.2021.647266
- 2,099 views
- 16 citations
ORIGINAL RESEARCH
Published on 19 Apr 2021
Endonasal CNS Delivery System for Blood-Brain Barrier Impermeant Therapeutic Oligonucleotides Using Heterotopic Mucosal Engrafting
doi 10.3389/fphar.2021.660841
- 3,067 views
- 9 citations
REVIEW
Published on 15 Apr 2021
Melatonin as a Chronobiotic and Cytoprotective Agent in Parkinson’s Disease
doi 10.3389/fphar.2021.650597
- 11,472 views
- 34 citations
ORIGINAL RESEARCH
Published on 27 Jan 2021
Acylated Ghrelin is Protective Against 6-OHDA-induced Neurotoxicity by Regulating Autophagic Flux
doi 10.3389/fphar.2020.586302
- 2,887 views
- 15 citations
ORIGINAL RESEARCH
Published on 11 Jan 2021
Contributive Role of TNF-α to L-DOPA-Induced Dyskinesia in a Unilateral 6-OHDA Lesion Model of Parkinson’s Disease
doi 10.3389/fphar.2020.617085
- 4,194 views
- 26 citations
CLINICAL TRIAL
Published on 30 Sep 2020
A Ketone Ester Drink Enhances Endurance Exercise Performance in Parkinson’s Disease
doi 10.3389/fnins.2020.584130
- 9,085 views
- 22 citations
Published in
Frontiers in Pharmacology
- Neuropharmacology
Participating Journals
Frontiers in Neurology
NeuropharmacologyOffline
- 2.7 impact factor
- 4.9 citescore
Frontiers in Neuroscience
- 3.2 impact factor
- 6.2 citescore
Frontiers in Psychiatry
NeuropharmacologyOffline
- 3.2 impact factor
- 6.2 citescore
Impact
- 54kTopic views
- 35kArticle views
- 16kArticle downloads